Bridin Murnion

2.6k total citations · 1 hit paper
65 papers, 1.7k citations indexed

About

Bridin Murnion is a scholar working on Public Health, Environmental and Occupational Health, Anesthesiology and Pain Medicine and Pharmacology. According to data from OpenAlex, Bridin Murnion has authored 65 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Public Health, Environmental and Occupational Health, 18 papers in Anesthesiology and Pain Medicine and 16 papers in Pharmacology. Recurrent topics in Bridin Murnion's work include Opioid Use Disorder Treatment (25 papers), Pain Management and Opioid Use (15 papers) and Cannabis and Cannabinoid Research (11 papers). Bridin Murnion is often cited by papers focused on Opioid Use Disorder Treatment (25 papers), Pain Management and Opioid Use (15 papers) and Cannabis and Cannabinoid Research (11 papers). Bridin Murnion collaborates with scholars based in Australia, United States and New Zealand. Bridin Murnion's co-authors include Jonathan Brett, Suzanne Nielsen, Paul Haber, Sarah N. Hilmer, Michael Farrell, Gabrielle Campbell, Louisa Degenhardt, Michael S. Leong, Wayne Hall and Eleanor Mitchell and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Pain.

In The Last Decade

Bridin Murnion

57 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies

2018 293 citations Emily Stockings, Gabrielle Campbell et al. Pain profile →

Peers

Countries citing papers authored by Bridin Murnion

Since Specialization

Citations

This map shows the geographic impact of Bridin Murnion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bridin Murnion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bridin Murnion more than expected).

Fields of papers citing papers by Bridin Murnion

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bridin Murnion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bridin Murnion. The network helps show where Bridin Murnion may publish in the future.

Co-authorship network of co-authors of Bridin Murnion

This figure shows the co-authorship network connecting the top 25 collaborators of Bridin Murnion. A scholar is included among the top collaborators of Bridin Murnion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bridin Murnion. Bridin Murnion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pregabalin dependence, withdrawal, suicidality and psychosis reports: A disproportionality analysis of the Australian adverse events database 2025 ·British Journal of Clinical Pharmacology ·(unknown), Ali Gholamrezaei, Bridin Murnion, Suzanne Nielsen, Claire E. Ashton‐James	1
2	A 3-year experience of an Australian short-stay Psychiatric, Alcohol and Non-prescription Drug Assessment Unit: unit activity and the patient experience 2025 ·Emergency Medicine Journal ·Jane E. Carland, (unknown), (unknown), Nadine Ezard, (unknown), (unknown), (unknown), Bridin Murnion, Richard O. Day, (unknown), (unknown), Jonathan Brett	0
3	Healthcare Practitioner and Other Professionals' Perspectives on Gabapentinoid Misuse and Dependence: A Systematic Review of Qualitative Studies 2025 ·European Journal of Pain ·(unknown), (unknown), Suzanne Nielsen, Claire E. Ashton‐James, Bridin Murnion	0
4	Pharmacists' views on the implementation of therapeutic drug monitoring in oncology 2025 ·Journal of Pharmacy Practice and Research ·Jane E. Carland, Bridin Murnion, (unknown), Jana Stojanova	0
5	Experiences of misuse and symptoms of dependence among people who use gabapentinoids: A qualitative systematic review 2024 ·International Journal of Drug Policy ·(unknown), (unknown), Suzanne Nielsen, Bridin Murnion, Claire E. Ashton‐James	4
6	Medicinal Mishap: Acute tacrolimus toxicity due to concomitant use of ritonavir (with nirmatrelvir as Paxlovid) 2024 ·Australian Prescriber ·(unknown), (unknown), D.R. Darley, Bridin Murnion	0
7	Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations 2023 ·The Medical Journal of Australia ·(unknown), (unknown), Lisa Bero, Fiona Blyth, Jason N. Doctor, (unknown), Yun‐Hee Jeon, Joanna C. Moullin, Bridin Murnion, Suzanne Nielsen, (unknown), Jonathan Penm, Emily Reeve, Sharon Reid, Janet Wale, Carl R. Schneider, Danijela Gnjidic	25
8	Evaluation of the Prescribing Skills Assessment implementation, performance and medical student experience in Australia and New Zealand 2023 ·British Journal of Clinical Pharmacology ·Paul K. L. Chin, Kellie A. Charles, Bridin Murnion, Treasure McGuire, Sarah N. Hilmer, Jennifer Martin, David Reith, David L. Joyce, Catherine Lucas, Nicholas H. G. Holford, Richard O. Day, Jennifer Schneider, Matthew Doogue, Catherine Han, (unknown), C. V. Harrison, (unknown)	4
9	Experiences of misuse and symptoms of dependence among people who use gabapentinoids: a qualitative systematic review protocol 2023 ·BMJ Open ·(unknown), Suzanne Nielsen, Bridin Murnion, Claire E. Ashton‐James	2
10	How do patients and staff in an opioid agonist treatment service view smoking cessation medications and e‐cigarettes? 2023 ·Drug and Alcohol Review ·(unknown), (unknown), Chenxi Lin, Apo Demirkol, Bridin Murnion	2
11	‘It’s a fragile open door’—enhancing COVID-19 vaccination rates in people receiving treatment for substance use disorder 2023 ·Journal of Public Health ·Bridin Murnion, Jane E. Carland, Meryem Jefferies, Michael Au, (unknown)	1
12	Current Insights on the Impact of Gamma-Hydroxybutyrate (GHB) Abuse 2022 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Bridin Murnion	29
13	Transferring patients from high-dose methadone to buprenorphine: A retrospective case series 2022 ·Journal of Opioid Management ·(unknown), (unknown), (unknown), (unknown), Bridin Murnion	3
14	Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies breakdown → 2018 ·Pain ·Emily Stockings, Gabrielle Campbell, Wayne Hall, Suzanne Nielsen, Dino Zagic, (unknown), Bridin Murnion, Michael Farrell, Megan Weier, Louisa Degenhardt	293
15	Understanding an emerging treatment population: Protocol for and baseline characteristics of a prospective cohort of people receiving treatment for pharmaceutical opioid dependence 2018 ·Drug and Alcohol Review ·Suzanne Nielsen, Nicholas Lintzeris, Bridin Murnion, Louisa Degenhardt, Raimondo Bruno, Paul Haber, Jennifer Johnson, Mark Hardy, (unknown), (unknown), Adrian Dunlop, Apo Demirkol, (unknown), Nghi Phung, (unknown), Briony Larance	5
16	CANNABINOIDS FOR THE TREATMENT OF CHRONIC NON-CANCER PAIN: AN OVERVIEW OF THE EVIDENCE 2018 ·Drug and Alcohol Review ·Emily Stockings, Gabrielle Campbell, Wayne Hall, Suzanne Nielsen, Dino Zagic, (unknown), Bridin Murnion, Michael Farrell, Megan Weier, Louisa Degenhardt	1
17	Treating codeine dependence with buprenorphine: Dose requirements and induction outcomes from a retrospective case series in New South Wales, Australia 2015 ·Drug and Alcohol Review ·Suzanne Nielsen, Raimondo Bruno, Bridin Murnion, Adrian Dunlop, Louisa Degenhardt, Apo Demirkol, Peter Muhleisen, Nicholas Lintzeris	9
18	Examination of opioid prescribing in Australia from 1992 to 2007 2009 ·Internal Medicine Journal ·Michael S. Leong, Bridin Murnion, Paul Haber	105
19	Targeted Pharmacotherapy of Evoked Phenomena in Neuropathic Pain: A Review of the Current Evidence 2007 ·Pain Medicine ·(unknown), Richard O. Day, Milton Cohen, Bridin Murnion, Raymond Garrick	7
20	Utility of urine drug screening: A Clinical audit 2007 ·Emergency Medicine Australasia ·Bridin Murnion, (unknown), Richard O. Day	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact